Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values

Figure 2

ROC curve analysis of individual markers and combinations of ACY1, SQSTM1, and GPC3 for discriminating between WDHCC and HGDN lesions. AUCs were 0.857 for ACY1, 0.837 for SQSTM1, 0.795 for GPC3, 0.935 for ACY1 + SQSTM1, 0.902 for ACY1 + GPC3, 0.921 for SQSTM1 + GPC3, 0.943 for ACY1 + SQSTM1 + GPC3.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us